BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 87203)

  • 21. Rheumatoid factor isotypes and circulating immune complexes in rheumatoid arthritis.
    Zlabinger GJ; Haberhauer G; Dax K; Menzel EJ; Bröll H
    Clin Exp Rheumatol; 1990; 8(2):113-9. PubMed ID: 2338008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
    Menzel J; Steffen C
    Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating immune complexes in mixed connective tissue disease.
    Halla JT; Volanakis JE; Schrohenloher RE
    Arthritis Rheum; 1979 May; 22(5):484-9. PubMed ID: 375940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta2 microglobulin, antibeta2 microglobulin activity and circulating immune complexes in rheumatoid arthritis. Serum and synovial study].
    Duquesnoy B; Asfour M; Santoro F; Vandemeulebroucke B; Hochart JP; Delcambre B
    Rev Rhum Mal Osteoartic; 1980; 47(7-9):481-7. PubMed ID: 6158754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
    Levinson SS; Goldman JO
    J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.
    Melsom RD; Horsfall AC; Schrieber L; Charles P; Maini RN
    Rheumatol Int; 1986; 6(5):227-31. PubMed ID: 3492027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of C1q- and conglutinin-binding immune complexes with high consumption of alpha-2-macroglobulin in synovial fluids of patients with rheumatoid arthritis.
    Borth W; Menzel JE
    Int Arch Allergy Appl Immunol; 1984; 75(1):92-6. PubMed ID: 6204949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating immune complexes and complement in rheumatoid arthritis.
    Duquesnoy B
    Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgE rheumatoid factor. Occurrence and diagnostic importance in comparison with IgM rheumatoid factor and circulating immune complexes.
    Herrmann D; Jäger L; Hein G; Henzgen M; Schlenvoigt G
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):302-7. PubMed ID: 1669588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
    Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
    Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibronectin binding with immunoglobulin aggregates and its association with rheumatic disorders.
    Carter SD; Scott DL; Elson CJ
    Br J Rheumatol; 1986 Nov; 25(4):353-8. PubMed ID: 3490895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immunity and composition of immune complexes in patients with rheumatoid arthritis, with special reference to IgE-containing immune complexes.
    De Clerck LS; Struyf NJ; Bridts CH; Francx L; Van Offel JF; Empsten FA; Westedt ML; Breedveld FC; Cats A; Stevens WJ
    Clin Exp Rheumatol; 1989; 7(5):485-92. PubMed ID: 2591122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immune complexes in the pathogenesis of rheumatoid arthritis].
    Lavrova TR
    Ter Arkh; 1978; 50(10):125-31. PubMed ID: 81534
    [No Abstract]   [Full Text] [Related]  

  • 39. [IgA rheumatoid factor formation in connection with complement activation and circulating immune complexes in chronic polyarthritis].
    Kullich W
    Wien Klin Wochenschr; 1994; 106(9):272-5. PubMed ID: 8023521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating immune complexes in patients with rheumatoid arthritis: correlation with disease activity.
    Levo Y; Fischel R; Ehrenfeld M
    J Rheumatol; 1981; 8(5):851-5. PubMed ID: 7310781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.